| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 30,000 | $20.00 | $600,132.00 | -7.4% | +25.7% | - | |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 138,614 | $33.20 | $4,602,369.80 | -58.0% | +13.3% | - | |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 18,889 | $32.89 | $621,259.21 | -41.2% | +13.7% | - | |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Megna Michael R | Chief Accounting Officer | Sell | 17,000 | $32.35 | $549,950.00 | -34.0% | +13.7% | - | |
| Aug 2, 2025 | BMY Bristol Myers Squibb Co | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 378 | $44.23 | $16,718.94 | -6.9% | +4.2% | - | |
| Aug 1, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $20.83 | $10,415.75 | -0.6% | +16.3% | - | |
| Aug 1, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Jover Placid | See "remarks" | Sell | 6,053 | $15.16 | $91,748.35 | -47.2% | +30.2% | - | |
| Aug 1, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Hughes Eric A | See "remarks" | Sell | 52,742 | $15.16 | $799,436.87 | -100% | +30.2% | - | |
| Aug 1, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 26,600 | $66.98 | $1,781,560.00 | -4.6% | -29.6% | - | |
| Jul 31, 2025 | TLRY Tilray Brands, Inc. | Gendel Mitchell | Global General Counsel | Buy | 6,000 | $0.58 | $3,496.20 | +0.9% | +134.1% | - | |
| Jul 31, 2025 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 340 | $3.43 | $1,166.13 | - | -5.8% | - | |
| Jul 31, 2025 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 1,712 | $3.43 | $5,872.20 | - | -5.8% | - | |
| Jul 31, 2025 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 340 | $3.43 | $1,166.13 | - | -5.8% | - | |
| Jul 31, 2025 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 168 | $3.44 | $577.91 | - | -5.8% | - | |
| Jul 30, 2025 | TLRY Tilray Brands, Inc. | Merton Carl A | Chief Financial Officer | Buy | 33,500 | $0.60 | $19,939.20 | +4.4% | +125.3% | - | |
| Jul 30, 2025 | TLRY Tilray Brands, Inc. | Simon Irwin D | President And CEO | Buy | 165,000 | $0.61 | $100,105.50 | +4.4% | +125.3% | - | |
| Jul 28, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 454 | $19.54 | $8,871.16 | -0.2% | +14.8% | - | |
| Jul 28, 2025 | LQDA Liquidia Corp | Boyle Dana | Chief Accounting Officer | Sell | 1,063 | $19.54 | $20,771.02 | -0.6% | +14.8% | - | |
| Jul 28, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,572 | $58.70 | $150,976.40 | -1.6% | -17.8% | - | |
| Jul 24, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 280,000 | $805.07 | $225,419,259.17 | - | +0.9% | - | |
| Jul 24, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $304.11 | $3,345,225.10 | -8.4% | +37.6% | - | |
| Jul 24, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 15,850 | $56.20 | $890,792.00 | -2.8% | -17.2% | - | |
| Jul 22, 2025 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 50,000 | $0.21 | $10,250.00 | - | - | - | |
| Jul 21, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 125,335 | $49.54 | $6,208,636.65 | -25.3% | +7.9% | - | |
| Jul 21, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 2,526 | $14.54 | $36,728.04 | -0.9% | +61.9% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.